Shandra Eisenga Human Cell and Tissue Product Safety Act

Bill 118 s 3733, also known as the Shandra Eisenga Human Cell and Tissue Product Safety Act, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to enhance the safety and regulation of human cell and tissue products in the United States.

The bill is named after Shandra Eisenga, a young woman who tragically lost her life due to complications from a contaminated human cell and tissue product. This incident highlighted the need for stricter regulations and oversight in this industry.

If passed, the Shandra Eisenga Human Cell and Tissue Product Safety Act would require all human cell and tissue products to undergo rigorous testing and screening for infectious diseases and other contaminants before being distributed for medical use. This would help prevent future tragedies like the one that befell Shandra Eisenga. Additionally, the bill would establish a national registry for human cell and tissue products, allowing for better tracking and monitoring of these products throughout the supply chain. This would help ensure that only safe and high-quality products are being used in medical procedures. Overall, the Shandra Eisenga Human Cell and Tissue Product Safety Act aims to improve the safety and quality of human cell and tissue products in the United States, ultimately protecting patients and preventing future tragedies.